Very proud of everyone on @SpecificBio and @megatev teams for their incredible contributions in showcasing efficient, precise and specific RNA-templated DNA repair with Dualase™ (TevCas9) gene editors! Preview of the work is now live: https://t.co/e0bVykx1ko
Excited to officially announce the closing of our seed round with @LumiraVentures and @adMare_Bio! Together we will be accelerating our Dualase gene editing platform and a pipeline of Dualase-based therapeutics.
https://t.co/dQyH6J8rZG
We awarded more than $1.8 million to three companies for early-stage research into potential genetic therapies for #cysticfibrosis as part of our Path to a Cure initiative. #CFResearch https://t.co/I6Jz7RMqGY